GS0051: Synthetic peptides for medical use; synthetic peptides for medical use, namely, synthetic peptides for the treatment of cancer; pharmaceutical preparations for cancer treatments, namely, immunotherapeutic treatments for cancerous tumors; medical preparations, namely, pharmaceuticals containing lipids, liposomes, and peptides for use in the treatment of cancer
GS0011: Biomedical compounds, namely, peptide substrates used in analyzing and detecting cancer cells for clinical or medical laboratory use
GS0421: Medical and pharmacological research services in the field of immunotherapy and cancer treatment; biological research, clinical research, and medical research all in the field of immunotherapies and cancer treatment; development of drug delivery agents being made from liposomes and peptides; development of drug delivery agents that facilitate the delivery of pharmaceuticals and pharmaceutical preparations
Case File Event Statements
7/20/2022 - 2 years ago
8 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDType:MAB2
7/20/2022 - 2 years ago
7 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEType:ABN2
1/6/2022 - 2 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILEDType:GNRN
1/6/2022 - 2 years ago
5 - NON-FINAL ACTION E-MAILEDType:GNRT
1/6/2022 - 2 years ago
4 - NON-FINAL ACTION WRITTENType:CNRT
1/4/2022 - 3 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
8/19/2021 - 3 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAMType:NWOS